我們已在上線!
進一步了解
ACGN
Aceragen Inc
ACGN
ACGN
已下市
ACGN已於2023年8月21日下市。
關於: Aceragen Inc is a clinical-stage biopharmaceutical company committed to transforming the care of people living with rare pulmonary and rheumatic diseases. The company portfolio includes late-stage programs based on well-established biological principles that are developing to be inventive therapeutics capable of addressing the unmet medical needs of individuals living with rare diseases.
員工: 26
新聞
正面
中性
負面
市場情緒
3個月
正面
0%
中性
0%
負面
0%
我們尚未收到任何關於ACGN的最新新聞文章。
價格圖表採用Lightweight Charts™實作